Apathy
58
15
16
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.2%
3 terminated out of 58 trials
89.3%
+2.7% vs benchmark
22%
13 trials in Phase 3/4
40%
10 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (58)
Accelerated rTMS for Post-Stroke Apathy
Accelerated rTMS vs. Sham for Stroke Apathy
In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
SENS'REM - SENSoriality and Multi-Sensory Emotional Reminiscences: a Pilot Study
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
Robotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)
Motivation and Methylphenidate
Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
The Effects of Apathy on Different Forms of Fatigue
Targeting Apathy With Music in Parkinson's Disease
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers
Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.
A Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease
A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Lifestyle Intervention for Improving Insulin Resistance and Concern for Health